Skip to NavigationSkip to content

News

A ruling which would force pharmaceutical companies to disclose the price of their drugs in television advertisements has been set aside by members...
Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and diversification of...
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic dermatitis in...
AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who have had at...
The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 million. The...
Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration (FDA) had approved the...
NICE has taken the decision to recommend the first ever first BRAF-targeted therapy for use on the NHS in England and Wales for post-surgery stage...
UCB has revealed new findings for its products Cimzia and bimekizumab in the treatment of moderate-to-severe chronic plaque psoriasis.
As Hurricane Florence begins to breach the Southeast Coast, major pharma firms have announced they are enacting contingency plans, including  ...
To find out more, check out this week’s Top 10 most popular articles on Pharmafile.com now!
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches